Back to search

University of Thessaly (UTH)

Διερεύνηση της ποιότητας ζωής και του άγχους σε ασθενείς με μη μυοδιηθητικό καρκίνο της ουροδόχου κύστης πριν και μετά τη χειρουργική επέμβαση

Abstract

dc:description

Background: Bladder cancer (BC) is one of the most common malignancies. Most of the new BC cases are diagnosed as non-muscle invasive BC (NMIBC), needing continuous follow up after primary endoscopic therapy. Adjuvant bladder therapy with chemo- or immuno- agents, apart from the initial diagnosis, the strict surveillance program and the risk of recurrence, may have a major impact on the patients’ physical and mental health. Purpose: The assessment of anxiety and quality of life (QoL) in patients who underwent surgery for NMIBC and followed a bladder instillation programme. Methods: This is a prospective analysis of patients with histopathologically confirmed NMIBCs. Eligible were all adult patients with a single or multiple NMIBCs who underwent a transurethral tumor resection and followed a therapy with either BCG or Epirubicin instillations. The SF-36 questionnaire Physical and Mental health aspects were used for QoL assessment. Similarly, the STAI-Y was introduced for the state (STAI-Y1) and trait anxiety (STAI-Y2) evaluation.Results:117 eligible patients were screened, with 108 entering finally the study; nine patients were excluded due to disease recurrence. 17 patients (15.7%) received Epirubicin (Ta-T1, Low Grade tumors), whereas 91 patients (84.3%) received BCG (T1, High Grade). Regarding SF-36 Physical a 6 months decrease was followed by an improvement at 12 months (p = 0.008). Similarly, an increase of the SF-36 Mental health score was identified (p = 0.03). In contrast to STAI-Y2 scores (p = 0.945), while in the STAI-Y1 a long-term reduction of the state anxiety was identified (p = 0.001). Preoperative SF-36 Physical was inversely correlated with age (p = 0.029), while absence of alcohol was associated with lower mental health (p = 0.003). Also, patients receiving BCG experienced increased stress levels at 3 months postoperatively and decreased levels at 6 months onwards, while treatment with Epirubicin reduced stress levels at 3 months but increased them at 6 months. As regards residence, it was found that this parameter can affect anxiety levels pre surgery. Conclusions: Patient QoL and anxiety improved during follow up. The assessment of the demographic characteristics of patients and the anxiety levels in patients with BC can affect their quality of life.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vaioulis, Alexandros
  • Βαϊούλης, Αλέξανδρος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50226

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vaioulis, Alexandros; Βαϊούλης, Αλέξανδρος. Διερεύνηση της ποιότητας ζωής και του άγχους σε ασθενείς με μη μυοδιηθητικό καρκίνο της ουροδόχου κύστης πριν και μετά τη χειρουργική επέμβαση. University of Thessaly (UTH), 2021. http://hdl.handle.net/10442/hedi/50226